GTHR Financials 07/16/2014 11:50:49 GeneThera, In

GTHR Financials 07/16/2014 11:50:49
GeneThera, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,084 1,771 1,110 474
Non-Recurring Items - - - -
Other 16 36 4 9
Operating Income (1,100) (1,807) (1,114) (483)
Income From Continuing Operations
Add'l Income/Expense Items 40 (3) (1) -
Earnings Before Interest and Tax (1,060) (1,811) (1,115) (483)
Interest Expense - 1 7 1
Earnings Before Tax (1,060) (1,812) (1,122) (484)
Income Tax - - - -
Minority Interest (3) (20) (21) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,057) (1,791) (1,101) (484)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,057) (1,791) (1,101) (484)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,057) (1,791) (1,101) (484)